Pyxis Oncology Inc (PYXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1992 | 09-1992 | 12-1991 | 03-1991 | 12-1990 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 11,897 | N/A | -673 | -673 | -5,090 |
| Depreciation Amortization | 616 | N/A | 396 | 396 | 368 |
| Other Working Capital | -7,743 | N/A | -5,547 | -5,547 | -263 |
| Other Operating Activity | 3,293 | 0 | 91 | 91 | 35 |
| Operating Cash Flow | $8,064 | $N/A | $-5,732 | $-5,732 | $-4,950 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,050 | N/A | -221 | -221 | -320 |
| Other Investing Activity | -30,380 | 0 | -6,933 | -6,933 | -1,964 |
| Investing Cash Flow | $-31,430 | $N/A | $-7,155 | $-7,155 | $-2,283 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 60,725 | 0 | 13,885 | 13,885 | 7,615 |
| Financing Cash Flow | $60,725 | $N/A | $13,885 | $13,885 | $7,615 |
| Beginning Cash Position | 1,514 | N/A | 516 | 516 | 134 |
| End Cash Position | 38,873 | N/A | 1,514 | 1,514 | 516 |
| Net Cash Flow | $37,359 | $N/A | $999 | $999 | $382 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,064 | N/A | -5,732 | -5,732 | -4,950 |
| Free Cash Flow | 8,064 | 0 | -5,732 | -5,732 | -4,950 |